[1]
“CLUSTERING OF COVID-19 VACCINES BY SARS-CoV-2 INFECTION LEVEL AFTER TWO VACCINATIONS”, JPJB, vol. 23, no. 1, pp. 1–10, Jan. 2023, doi: 10.17654/0973514323001.